Lataa...
Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models
INTRODUCTION: Trastuzumab dramatically improves survival in breast cancer patients whose tumor overexpresses HER2. A subpopulation of cells in human breast tumors has been identified with characteristics of cancer stem cells. These breast cancer stem-like cells (BCSCs) rely on HER2 signaling for sel...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3532453/ https://ncbi.nlm.nih.gov/pubmed/23284608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0046613 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|